Microbiota-dependent proteolysis of gluten subverts diet-mediated protection against type 1 diabetes

Cell Host Microbe. 2023 Feb 8;31(2):213-227.e9. doi: 10.1016/j.chom.2022.12.009. Epub 2023 Jan 4.

Abstract

Diet and commensals can affect the development of autoimmune diseases like type 1 diabetes (T1D). However, whether dietary interventions are microbe-mediated was unclear. We found that a diet based on hydrolyzed casein (HC) as a protein source protects non-obese diabetic (NOD) mice in conventional and germ-free (GF) conditions via improvement in the physiology of insulin-producing cells to reduce autoimmune activation. The addition of gluten (a cereal protein complex associated with celiac disease) facilitates autoimmunity dependent on microbial proteolysis of gluten: T1D develops in GF animals monocolonized with Enterococcus faecalis harboring secreted gluten-digesting proteases but not in mice colonized with protease deficient bacteria. Gluten digestion by E. faecalis generates T cell-activating peptides and promotes innate immunity by enhancing macrophage reactivity to lipopolysaccharide (LPS). Gnotobiotic NOD Toll4-negative mice monocolonized with E. faecalis on an HC + gluten diet are resistant to T1D. These findings provide insights into strategies to develop dietary interventions to help protect humans against autoimmunity.

Keywords: celiac disease; diet and autoimmunity; insulin secretion regulation; microbial proteolysis of gluten; microbiota and autoimmunity; type 1 diabetes.

MeSH terms

  • Animals
  • Diabetes Mellitus, Type 1* / prevention & control
  • Diet
  • Glutens
  • Humans
  • Mice
  • Mice, Inbred NOD
  • Microbiota*
  • Proteolysis

Substances

  • Glutens